EDIT-301 Program Update: RUBY and EdiTHAL Trial Data Update. Presented in a Company-sponsored Virtual Event. June 12, 2023.

Sep

9

Editas Medicine Reports Inducement Grants to New Chief Medical Officer

Sep

8

Editas Medicine Appoints Dan Ory, M.D., as Chief Medical Officer

Sep

1

Editas Medicine to Participate in Upcoming Investor Conferences